secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioScience Health Innovations, Inc. (BHIC)
CIK:        0001784440
Form:       8-K
Filed at:   2023-02-17T23:59:59+00:00
Accession:  0001185185-23-000148
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nowtransit to issue 85.39% stake for Best Labs acquisition in share exchange
----------------------------------------------------------------------------

- Nowtransit acquires Best Labs via share exchange; Best shareholders receive 34.37M shares (85.39% post-exchange) for 100% of Best.
- Justin Earl resigns as CEO; Darren Lopez (Best CEO) becomes CEO of combined company.
- Justin Earl remains on board; Darren Lopez and John Chymboryk appointed directors.
- Closing conditions include audited financials and Form 10 filing; target close by Feb 24, 2023.
- Best shareholders subject to 12-month lock-up and no registration for 12 months; shares restricted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1784440/000118518523000148/0001185185-23-000148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1784440/000118518523000148/nowtransit20230217_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-23-000148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer